An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
Clinical trial NCT05500092 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05500092
- Sponsor
- Montefiore Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-25
- Primary completion
- 2025-07-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.